Evaluation of Parotid Salivary Gland Echo Texture by Ultrasound Examinations and Correlation With Whole-Body Scintigraphy After Radioiodine Therapy in Patients With Differentiated Thyroid Carcinoma

Imagem de Miniatura
Arquivos
art_LIMA_Evaluation_of_Parotid_Salivary_Gland_Echo_Texture_by_2020.PDF (2.48 MB)
Citações na Scopus
5
Tipo de produção
article
Data de publicação
2020
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
Citação
JOURNAL OF ULTRASOUND IN MEDICINE, v.39, n.9, p.1811-1818, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objectives This study aimed to evaluate the echo texture of the parotid salivary glands before and after radioiodine therapy (RIT) using ultrasound (US) images in patients with differentiated thyroid cancer and to evaluate the correlations between post-RIT whole-body scintigraphy (WBS) images and US image patterns in salivary and cervical areas. Methods A retrospective study was performed with data on demographic and clinical information, US examinations, and WBS images collected through medical recordings. Results Comparing the US features before and after RIT, significant echo texture heterogeneity was found in 31.3% of all patients evaluated. When evaluated according to the level of iodine 131 (I-131) radioactivity (<5.6, 5.6-<9.3, and >= 9.3 GBq), echo texture heterogeneity was significantly associated with the 5.6-GBq I-131 radioactivity group (P < .001). No association was found for any level of I-131 post-RIT WBS uptake intensity and changes in US feature patterns. Conclusions Ultrasound may be a useful tool for evaluating chronic sialadenitis after RIT, and the I-131 uptake intensity using a routine post-RIT WBS is not associated with US echo texture changes.
Palavras-chave
iodine 131, sialadenitis, thyroid cancer, ultrasound, whole-body scintigraphy
URI
https://observatorio.fm.usp.br/handle/OPI/37715
Referências
  1. Alexander C, 1998, J NUCL MED, V39, P1551
  2. Almeida JP, 2011, HEAD NECK-J SCI SPEC, V33, P686, DOI 10.1002/hed.21520
  3. Brozzi F, 2013, J ENDOCRINOL INVEST, V36, P153, DOI 10.3275/8335
  4. Hassan FU, 2015, EUR THYROID J, V4, P239, DOI 10.1159/000435836
  5. Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020
  6. Höfling Danilo Bianchini, 2008, Radiol Bras, V41, P409, DOI 10.1590/S0100-39842008000600012
  7. Jo KS, 2014, NUCL MED MOLEC IMAG, V48, P203, DOI 10.1007/s13139-014-0274-4
  8. Kim DW, 2015, ULTRASOUND MED BIOL, V41, P2640, DOI 10.1016/j.ultrasmedbio.2015.06.010
  9. LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
  10. Lee HN, 2015, CLIN IMAG, V39, P396, DOI 10.1016/j.clinimag.2014.12.018
  11. Lee SM, 2013, ANN NUCL MED, V27, P700, DOI 10.1007/s12149-013-0735-3
  12. Lopez Alvarenga R, 2009, REV CIR TRAUMATOL BU, V9, P29
  13. Roh SS, 2016, AM J ROENTGENOL, V207, P1077, DOI 10.2214/AJR.15.15776
  14. Rosário Pedro W.S., 2004, Arq Bras Endocrinol Metab, V48, P310, DOI 10.1590/S0004-27302004000200016
  15. Santhanam P, 2019, ENDOCRIN METAB CLIN, V48, P239, DOI 10.1016/j.ecl.2018.11.008
  16. Sapienza Marcelo Tatit, 2005, Arq Bras Endocrinol Metab, V49, P341, DOI 10.1590/S0004-27302005000300004
  17. Szujo S, 2017, ONCOTARGET, V8, P79825, DOI 10.18632/oncotarget.19781
  18. Vieira ACF, 2011, REV ODONTOL U CID SA, V23, P216
  19. Ward Laura S., 2004, Arq Bras Endocrinol Metab, V48, P126, DOI 10.1590/S0004-27302004000100014
  20. Ying M, 2007, ULTRASOUND MED BIOL, V33, P1244, DOI 10.1016/j.ultrasmedbio.2007.02.016

Coleções
Artigos e Materiais de Revistas Científicas - FM/MDR
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - LIM/24
Artigos e Materiais de Revistas Científicas - LIM/43
Artigos e Materiais de Revistas Científicas - LIM/44
Carregar mais